Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study

Basit Öğe Kaydı
dc.contributor.authorKaradag, Serhat
dc.contributor.authorOzturk, Savas
dc.contributor.authorArici, Mustafa
dc.contributor.authorGorgulu, Numan
dc.contributor.authorAkcali, Esra
dc.contributor.authorPembegul, Irem
dc.contributor.authorAtes, Kenan
dc.date.accessioned2026-06-19T06:41:04Z
dc.date.available2026-06-19T06:41:04Z
dc.date.issued2023
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractPurpose Coronavirus disease 2019 (COVID-19) has a higher mortality in the presence of chronic kidney disease (CKD). However, there has not been much research in the literature concerning the outcomes of CKD patients in the post-COVID-19 period. We aimed to investigate the outcomes of CKD patients not receiving renal replacement therapy. Methods In this multicenter observational study, we included CKD patients with a GFR < 60 ml/min/1.73 m(2) who survived after confirmed COVID-19. Patients with CKD whose kidney disease was due to diabetic nephropathy, polycystic kidney disease and glomerulonephritis were not included in this study. CKD patients with similar characteristics, who did not have COVID-19 were included as the control group. Results There were 173 patients in the COVID-19 group and 207 patients in the control group. Most patients (72.8%) were treated as inpatient in the COVID-19 group (intensive care unit hospitalization: 16.7%, acute kidney injury: 54.8%, needing dialysis: 7.9%). While there was no significant difference between the baseline creatinine values of the COVID-19 group and the control group (1.86 and 1.9, p = 0.978, respectively), on the 1st month, creatinine values were significantly higher in the COVID-19 group (2.09 and 1.8, respectively, p = 0.028). Respiratory system symptoms were more common in COVID-19 patients compared to the control group in the 1st month and 3rd month follow-ups (p < 0.001). Mortality at 3 months after the diagnosis of COVID-19 was significantly higher in the COVID-19 group than in the control group (respectively; 5.2% and 1.4%, p:0.037). Similarly, the rate of patients requiring dialysis for COVID-19 was significantly higher than the control group (respectively; 8.1% and 3.4%, p: 0.045). Conclusions In CKD patients, COVID-19 was associated with increased mortality, as well as more deterioration in kidney function and higher need for dialysis in the post-COVID-19 period. These patients also had higher rate of ongoing respiratory symptoms after COVID-19.
dc.description.sponsorshipTurkish Society of Nephrology
dc.description.sponsorshipThe study was funded by Turkish Society of Nephrology.
dc.identifier.doi10.1007/s11255-022-03329-8
dc.identifier.endpage408
dc.identifier.issn0301-1623
dc.identifier.issn1573-2584
dc.identifier.issue2
dc.identifier.orcid0000-0001-9208-7972
dc.identifier.orcid0000-0001-7651-7282
dc.identifier.orcid0000-0002-4055-7896
dc.identifier.orcid0000-0001-9431-8068
dc.identifier.orcid0000-0002-1815-5532
dc.identifier.pmid35951255
dc.identifier.scopus2-s2.0-85136934563
dc.identifier.scopusqualityQ2
dc.identifier.startpage399
dc.identifier.urihttps://doi.org/10.1007/s11255-022-03329-8
dc.identifier.urihttps://hdl.handle.net/20.500.12899/6057
dc.identifier.volume55
dc.identifier.wosWOS:000839493800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofInternational Urology and Nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260612
dc.subjectCovid-19
dc.subjectCkd
dc.subjectOutcomes
dc.titlePost-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu